Teresa L. Young
EVP, Chief Commercial & Strategy Officer · Seres Therapeutics, Inc.
- 2024
- Feb 18, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Teresa L. Young files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew R. Henn - $23K in MCRB purchases and sales in the last 12 months
- Eric D. Shaff - $9K in MCRB purchases and sales in the last 12 months
- Thomas Desrosier - $3K in MCRB purchases and sales in the last 12 months
- Kelly Brady - $735 in MCRB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Teresa L. Young?
Teresa L. Young is a corporate insider, tracked as EVP, Chief Commercial & Strategy Officer of Seres Therapeutics, Inc. (MCRB). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Teresa L. Young last file a Form 4?
The most recent primary Form 4 on record is dated 18 February 2026, one of 6 filings going back to 2024.
Has Teresa L. Young been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($22K) across all tracked filings.
